Bilateral choroidal effusion following vaccination against SARS-CoV-2 virus

Abstract

An 80-year-old systemically stable female presented with sudden blurring of vision post the first dose of CovishieldTM, a non-replicating viral vector vaccine. On examination, she was found to have bilateral serous choroidal effusions. A thorough systemic and ocular workup was performed to rule out other causes of choroidal effusion. The effusions resolved with tapering doses of oral and systemic steroids. To the best of our knowledge, at the time of submission, this is the first case of choroidal effusion being reported after the coronavirus disease 2019 (COVID-19) vaccine.

Keywords

• choroidal effusion
• covid-19 vaccine
• covishield
• non-replicating viral vector vaccine
• sars-cov-2 infection